Our findings that miR-148a dysregulation correlated with USP4 in the tumor samples and that patients having high USP4 showed a tendency to have high TNM stage (TNM stage II-III) support the role of USP4 in the transition of HCC to a malignant phenotype. This evidence concerns the gene USP4 and hepatocellular carcinoma.